NCT06016075View on ClinicalTrials.gov

Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

January 1, 2026

Conditions
Kidney Cancer
Interventions
DEVICE

Hyperpolarised MRI

Hyperpolarised 13C-pyruvate injection while laying in the MRI scanner. Non-radioactive, no risk, approved for use in humans.

DEVICE

Sodium MRI

MRI procedure as a regular MRI scan, the only change is us using a different sort of equipment so we are able to detect sodium.

DEVICE

Deuterium metabolic imaging (DMI) MRI

Drink of a sugar drink 90min before the MRI scan. Non-radioactive, no risk, approved for use in humans.

Trial Locations (1)

CB2 0QQ

RECRUITING

University Department of Radiology, Cambridge

All Listed Sponsors
lead

University of Cambridge

OTHER